PBOV1 promotes prostate cancer proliferation by promoting G1/S transition

被引:14
|
作者
Pan, Tiejun [1 ]
Wu, Rongpei [2 ]
Liu, Bo [1 ]
Wen, Handong [1 ]
Tu, Zhong [1 ]
Guo, Jun [1 ]
Yang, Jiarong [1 ]
Shen, Guoqiu [1 ]
机构
[1] Guangzhou Mil Command, Dept Urol, Wuhan Gen Hosp, Wuhan 430070, Hubei, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2016年 / 9卷
关键词
prostate cancer; PBOV1; cell proliferation; G(1)/S transition; CDK INHIBITORS; HEDGEHOG; PROGRESSION; PATHWAY; CELLS;
D O I
10.2147/OTT.S92682
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Prostate cancer (PC) is one of the leading causes of cancer death in men, and thus, finding new regulators is critical for PC therapy. Prostate and breast cancer overexpressed 1 (PBOV1) is overexpressed in breast, prostate, and bladder cancers, as it is upregulated in the serum of patients with PC, but the role of PBOV1 in PC has not been studied. In this article, we found that PBOV1 was indeed overexpressed in PC cells; PBOV1 overexpression promoted cell proliferation and colony formation ability and arrested cell cycle in the G(0)/G(1) phase and tumorigenicity ability in vitro, whereas knockdown of PBOV1 reduced these effects. Further analysis of PBOV1 overexpression inhibited cell cycle inhibitors, P21 and P27, and increased the phosphorylation level of Rb and cyclin D1 expression, suggesting that PBOV1 promoted cell proliferation through promoting G(1)/S transition.
引用
收藏
页码:787 / 795
页数:9
相关论文
共 50 条
  • [41] hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity
    Xing Dai
    YuJing Wu
    XiaoYi Jia
    Yan Chang
    HuaXun Wu
    Chun Wang
    HengShi Chen
    WenSheng Chen
    Qiong Huang
    Wei Wei
    Immunologic Research, 2016, 64 : 978 - 987
  • [42] hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity
    Dai, Xing
    Wu, YuJing
    Jia, XiaoYi
    Chang, Yan
    Wu, HuaXun
    Wang, Chun
    Chen, HengShi
    Chen, WenSheng
    Huang, Qiong
    Wei, Wei
    IMMUNOLOGIC RESEARCH, 2016, 64 (04) : 978 - 987
  • [43] G1/S TRANSITION AND CELL POPULATION DYNAMICS
    Bekkal-Brikci, Fadia
    Chiorino, Giovanna
    Boushaba, Khalid
    NETWORKS AND HETEROGENEOUS MEDIA, 2009, 4 (01) : 67 - 90
  • [44] Regulation of the G1 to S transition by the ubiquitin pathway
    DeSalle, LM
    Pagano, M
    FEBS LETTERS, 2001, 490 (03): : 179 - 189
  • [45] Regulation of G1/S transition in mammalian cells
    Guevara, C
    Korver, W
    Mahony, D
    Parry, D
    SeghezzI, W
    Shanahan, F
    Lees, E
    KIDNEY INTERNATIONAL, 1999, 56 (04) : 1182 - 1182
  • [46] PBOV1 Is a Human De Novo Gene with Tumor-Specific Expression That Is Associated with a Positive Clinical Outcome of Cancer
    Samusik, Nikolay
    Krukovskaya, Larisa
    Meln, Irina
    Shilov, Evgeny
    Kozlov, Andrey P.
    PLOS ONE, 2013, 8 (02):
  • [47] KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/FOXO1 signaling
    Ye, Run-yi
    Kuang, Xia-ying
    Zeng, Hui-juan
    Shao, Nan
    Lin, Ying
    Wang, Shen-ming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (08)
  • [48] 1α,25-dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells
    Istfan, N. W.
    Person, K. S.
    Holick, M. F.
    Chen, T. C.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 726 - 730
  • [49] Mitochondrial micropeptide STMP1 promotes G1/S transition by enhancing mitochondrial complex IV activity
    Sang, Ye
    Liu, Jin-Yu
    Wang, Feng-Yi
    Luo, Xiao-Yu
    Chen, Zi-Qi
    Zhuang, Shi-Mei
    Zhu, Ying
    MOLECULAR THERAPY, 2022, 30 (08) : 2844 - 2855
  • [50] Extracellular vesicles-transported lncRNA BCDR1 promotes tumor cell proliferation and therapy resistance via upregulating G1/S-phase transition in breast cancer
    Zhang, Qi
    Xiu, Bingqiu
    Chi, Yayun
    Wu, Jiong
    CANCER RESEARCH, 2023, 83 (05)